Status | Study |
Terminated |
Study Name: Can GnRH Agonist Trigger Prevent Ovarian Hyperstimulation Syndrome? Condition: Ovarian Hyperstimulation Syndrome Date: 2012-10-20 Interventions: Drug: Triptorelin 0.2 mg A single bolus of 0.2 mg triptorelin given 34-36 hours before oocyte retrieval. |
Completed |
Study Name: Controlled Ovarian Stimulation by HP-hMG for IVF / ICSI Cycles: Study on Ovarian Hyper Stimulation Syndrome in a Cohort of Women From 18 to 36 Years Old. Condition: Ovarian Hyperstimulation Syndrome (OHSS) Date: 2012-10-03 Interventions: Other: Highly purified menotropin (HP- hMG) treatment No intervention: patients treated by highly purifi |
Active, not recruiting |
Study Name: Study of Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in In Vito Fertilization Cycles and Derivation of OHSS Biomarkers Condition: Ovarian Hyperstimulation Syndrome Date: 2012-02-15 Interventions: Drug: Cabergoline Cabergoline |
Completed |
Study Name: Endometrial Receptivity After GnRH Agonist Triggering Condition: Ovarian Hyperstimulation Syndrome Date: 2011-12-20 Interventions: Drug: hCG single shot of 6500 |
Completed |
Study Name: Calcium for Prevention of Ovarian Hyperstimulation Syndrome Condition: Ovarian Hyperstimulation Syndrome Date: 2011-08-31 Interventions: Drug: calcium |
Completed |
Study Name: Double GnRH Antagonist Daily Dose in Hyperresponding IVF/ICSI Cycles May Prevent the OHSS Condition: Ovarian Hyperstimulation Syndrome Date: 2011-06-30 |
Completed |
Study Name: GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation Syndrome Condition: Ovarian Hyperstimulation Syndrome Effects of Gonadotropin Date: 2010-12-23 Interventions: Drug: GnRH antagonist (Cetrorelix) |
Withdrawn |
Study Name: Administration of Increased Dose of GnRH Antagonist for Coasting for Decreasing the Risk for Ovarian Hyperstimulation Syndrome( OHSS) Condition: Administration of Increased Dose of GnRH Antagonist for Coasting for Decreasing the Risk for Ovarian Hyperstimulation Syndrome( OHSS) Date: 2010-04-22 Interventions: Drug: Cetrotide |
Completed |
Study Name: Administration of Methylprednisolone for Prevention of Ovarian Hyper Stimulation Syndrome Condition: Ovarian Hyperstimulation Syndrome Date: 2009-11-13 Interventions: Drug: Methylprednisolone Admin |
Completed |
Study Name: The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte Donors Condition: Ovarian Hyperstimulation Syndrome Date: 2009-03-21 Interventions: Drug: Cetrotide acetate cetrotide acetate is a GnRH antagonist. The dose is 3 mg once on the day of oocy |